As the US FDA gets to grips with its new focus on nicotine as a single marketplace, it is planning to take a fresh look at one of the longest-established non-combustible forms of the substance – nicotine replacement therapy
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.